Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001516551-25-000010
Filing Date
2025-02-26
Accepted
2025-02-26 17:43:44
Documents
1
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740609817.html 4  
1 FORM 4 wk-form4_1740609817.xml 4 3879
  Complete submission text file 0001516551-25-000010.txt   5596
Mailing Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
DHILLON PUNIT (Reporting) CIK: 0001425052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42009 | Film No.: 25671730

Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)